June 17, 2024

Veterinary Medicine Market Size To Cross USD 93.67 Bn By 2032

The global veterinary medicine market size accounted for US$ 45.71  Bn in 2022 and is projected to reach around USD 93.67 Bn by 2032, growing at a CAGR of 7.43% from 2023 to 2032.

Veterinary Medicine Market Size 2023 To 2032 - Precedence Statistics

Report Summary

The global veterinary medicine market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the veterinary medicine market across the globe.

A comprehensive estimate on the veterinary medicine market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of veterinary medicine during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2584

Veterinary Medicine Market Report Scope

Report CoverageDetails
Market Size in 2023USD 49.11 Billion
Market Size by 2032USD 93.67 Billion
Growth Rate from 2023 to 2032CAGR of 7.43%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Animal Type, By Product, By Mode of Delivery and By End-User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized veterinary medicine market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Artificial Intelligence (AI) Chip Market Size Analysis 2023 To 2032

Veterinary Medicine Market Players

The report includes the profiles of key veterinary medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Zoetis
  • Biogenesis Bago
  • Neogen Corp.
  • Hester Biosciences
  • Phibro Animal Health
  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC

Market Segmentation

By Animal Type

  • Production
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Fish
  • Companion
    • Dogs
    • Cats
    • Horses
    • Others

By Product

  • Biologics
    • Vaccine
    • Live Attenuated Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Others
  • Others
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Others
  • Medicated Feed Additives

By Mode of Delivery

  • Oral
    • Powder
    • Tablets
  • Parenteral
    • Suspension
    • Topical
    • Carrier
  • Other

By End-User

  • Reference Laboratories
  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Veterinary Medicine Market 

5.1. COVID-19 Landscape: Veterinary Medicine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Veterinary Medicine Market, By Animal Type

8.1. Veterinary Medicine Market, by Animal Type, 2023-2032

8.1.1. Production

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Companion

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Veterinary Medicine Market, By Product

9.1. Veterinary Medicine Market, by Product, 2023-2032

9.1.1. Biologics

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Others

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Pharmaceuticals

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Medicated Feed Additives

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Veterinary Medicine Market, By Mode of Delivery 

10.1. Veterinary Medicine Market, by Mode of Delivery, 2023-2032

10.1.1. Oral

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Parenteral

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Veterinary Medicine Market, By End-User 

11.1. Veterinary Medicine Market, by End-User, 2023-2032

11.1.1. Reference Laboratories

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Point-of-care Testing/In-house Testing

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Veterinary Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Veterinary Medicine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.4. Market Revenue and Forecast, by End-User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 13. Company Profiles

13.1. Ceva Sante Animale

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Vetoquinol S.A.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Zoetis

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Biogenesis Bago

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Neogen Corp.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Hester Biosciences

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Phibro Animal Health

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ceva Sante Animale

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vetoquinol S.A.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Dechra Pharmaceuticals PLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com